Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
Sponsor
Beijing Chest Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05770063
Collaborator
(none)
86
2
4.5
Study Details
Study Description
Brief Summary
To investigate whether compound amino acid supplementation can further promote protein synthesis and improve nutritional status for lung cancer patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
Anticipated Study Start Date
:
Apr 15, 2023
Anticipated Primary Completion Date
:
Jul 30, 2023
Anticipated Study Completion Date
:
Aug 30, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: intervention group compound amino acid supplement |
Dietary Supplement: amino acid tablet
multiple essential amino acids supplements
|
| Placebo Comparator: control group placebo |
Dietary Supplement: amino acid tablet
multiple essential amino acids supplements
|
Outcome Measures
Primary Outcome Measures
- Concentration of albumin [after 42 days after the intervention]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
NRS2002 >=3 scores
-
lung cancer patients
-
low albumin or hemoglobin
-
informed consent
Exclusion Criteria:
-
Acute and critical patients;
-
Severe liver and kidney dysfunction;
-
Patients with gastrointestinal bleeding or intestinal obstruction;
-
Pregnant women, lactating women, people with mental illness, and people without independent behavior ability.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Beijing Chest Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Zhuo Li,
Beijing Chest Hospital,
Beijing Chest Hospital
ClinicalTrials.gov Identifier:
NCT05770063
Other Study ID Numbers:
- YNLX-2022-011
First Posted:
Mar 15, 2023
Last Update Posted:
Mar 15, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: